Cite
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
MLA
Jacek Gronwald, et al. “Cancer Risks in First-Degree Relatives of CHEK2 Mutation Carriers: Effects of Mutation Type and Cancer Site in Proband.” British Journal of Cancer, vol. 100, Apr. 2009, pp. 1508–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72ee34a4ce98fd89186cb59bbb873949&authtype=sso&custid=ns315887.
APA
Jacek Gronwald, Jan Lubinski, D Wokolowczyk, Tomasz Huzarski, Marek Szwiec, W Piesiak, Bohdan Górski, Janina Suchy, Tomasz Byrski, Ping Sun, Tadeusz Dębniak, Steven A. Narod, Cezary Cybulski, & M Matuszewski. (2009). Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. British Journal of Cancer, 100, 1508–1512.
Chicago
Jacek Gronwald, Jan Lubinski, D Wokolowczyk, Tomasz Huzarski, Marek Szwiec, W Piesiak, Bohdan Górski, et al. 2009. “Cancer Risks in First-Degree Relatives of CHEK2 Mutation Carriers: Effects of Mutation Type and Cancer Site in Proband.” British Journal of Cancer 100 (April): 1508–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72ee34a4ce98fd89186cb59bbb873949&authtype=sso&custid=ns315887.